XACT OMXC25 ESG A1 DKK | XACTC25Registrer dig for at låse op for ratings |
Fondens performance | 31-12-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 35,5 | 18,1 | -12,1 | 10,6 | 0,1 | |
+/-Kat | 4,8 | -1,4 | 3,6 | 2,0 | -5,5 | |
+/-Indeks | - | - | - | - | 7,3 | |
Kategori: Aktier - Danmark | ||||||
Kategoribenchmark: Morningstar Denmark TME NR DKK |
Oversigt | ||
Closing Price 27-01-2025 | DKK 189,00 | |
Kursændring 1 dag | 0,46% | |
Morningstar Kategori™ | Aktier - Danmark | |
Omsætning | 45030 | |
Børs | COPENHAGEN STOCK EXCHANGE | |
ISIN | SE0011452127 | |
Markedsværdi i alt (mio.) 31-12-2024 | DKK 4309,47 | |
Seneste TNA(mio.) 27-01-2025 | DKK 4319,44 | |
Løbende omkostning 02-01-2025 | 0,21% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: XACT OMXC25 ESG A1 DKK | XACTC25 |
The fund is an exchange-traded index fund and its objective is to follow the performance of the OMX Copenhagen 25 Index as closely as possible. OMX Copenhagen 25 Index is a market-value weighted index consisting of the 25 most-traded equities on the Copenhagen Stock Exchange. The index applies weight restrictions from individual issuers (capping). The composition of the index is normally adjusted bi-annually with regard to the transferable securities included as well as the percentage of the index to ensure sensitivity to market performance. The selection criteria and other adjustments to the composition of the index are governed by the Nasdaq OMX Copenhagen 25 Index Methodology. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Christian Sopov 04-02-2019 | ||
Startdato 04-02-2019 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
OMX Copenhagen 25 ESG Responsible NR | Morningstar Denmark TME NR DKK |
Target Market | ||||||||||||||||||||
|
Formuefordeling XACT OMXC25 ESG A1 DKK | XACTC25 | 31-12-2024 |
|
|
Top 5 placeringer | Sektor | % |
DSV AS | Industri | 15,47 |
Novo Nordisk AS Class B | Healthcare | 12,71 |
Novonesis (Novozymes) B Class B | Materialer | 8,42 |
Danske Bank AS | Finans | 7,99 |
Coloplast AS Class B | Healthcare | 7,21 |
Øget Mindsket Ny siden sidste portefølje | ||
XACT OMXC25 ESG A1 DKK | XACTC25 |